-
SpeichernDas Eingabefeld wird
gespeichert wenn Sie das Feld
verlassen oder hier klicken.↓USDISIN CH0012005267-
NovartisBörse SIX Swiss Exchange ZürichISIN CH0012005267 WKN: 904278Symbol NOVN.SW
-
NovartisBörse Börse MünchenEURSymbol NOTA
-
NOVARTIS AG-REGBörse Gettex System der Börse MünchenEURSymbol NOT
-
NOVARTIS AG-REGBörse Börse DüsseldorfEURSymbol NOT
-
NOVARTIS AG-REGBörse Börse StuttgartEURSymbol NOT
-
NOVARTIS AG-REGBörse Börse MünchenEURSymbol NOT
-
NOVARTIS AG-REGBörse Börse FrankfurtEURSymbol NOT
-
NovartisBörse Quotrix System der Börse DüsseldorfEURSymbol NOTA
-
NovartisBörse Tradegate System der Deutsche Börse AG (60%)EURSymbol NOTA
-
NovartisBörse Gettex System der Börse MünchenEURSymbol NOTA
-
NOVARTIS AG-REGBörse Quotrix System der Börse DüsseldorfEURSymbol NOT
-
NovartisBörse Börse DüsseldorfEURSymbol NOTA
-
NovartisBörse Börse StuttgartEURSymbol NOTA
-
NOVARTIS AG-REGBörse Tradegate System der Deutsche Börse AG (60%)EURSymbol NOT
-
NOVARTIS AG-REGBörse Börse BerlinEURSymbol NOT
-
NOVARTIS AG-REGBörse Börse HamburgEURSymbol NOT
-
NovartisBörse NYSE New York Stock ExchangeISIN US66987V1098 WKN: 907122USDSymbol NVS
-
ISIN CH0012005267 WKN: 904278USDSymbol NOVN
-
NovartisBörse BVMF
-
NovartisBörse London Stock Exchange
-
Symbol NOTA
-
Symbol NOTA
-
CHF
-
MXN
-
USD
-
NovartisBörse Bolsa de Comercio de Buenos Aires
-
ISIN CH0012005267
WKN 904278
Symbol NOVN
Währung
USD
Firmenname
Novan, Inc
Marktkapitalisierung
118.240.562.752 (+- 54%)
Die einen sagen so, die anderen so... Es gibt 3 Datenquellen:
218.646.976 oder 172.940.000.000 oder 181.563.041.280
Mitarbeiter
54.012 (+- 100%)
Die einen sagen so, die anderen so... Es gibt 2 Datenquellen:
23 oder 108.000 Mitarbeiter
Anzahl Aktien
2.265.008.000
KGV
17.9
EBITDA -24.745.000
Buchwert 0.02
Zahlte zuletzt am 04.03.2021 eine Dividende von 3,264 . Seit damals wurde keine Dividende mehr ausgeschüttet Übersicht
Novartis underperformed den DAX um -9 % (+20 % Dividenden) vom 30.04.2014 bis 31.03.2020
Die letzten Quartalsergebnisse Erwarteter Gewinn je Aktie beim aktuellen Wert von 78,77 CHF +0,12%
Letzte Communitymeinungen
- Ein User war zuletzt bullisch
- Im Alpha-Tester Battle 2021
-
Jen
Ein User hat Novartis abonniert.
Aktionärsstruktur der Novan, Inc
Portrait der Novartis Aktie
Das Unternehmen Novan, Inc aus Schweiz beschäftigt 54.012 Mitarbeiter und ist in den Bereichen Chemie & Pharma, Pharmazeutika, Medizinische Produkte / Medizintechnik, Biotechnologie, Pharma tätig.
Die Novartis Aktie hat inklusive der Dividendenausschüttungen seit dem 30.04.2014 eine Gesamtrendite von 14% erwirtschaftet
Das Unternehmen Novan, Inc ist in mehr als 80 ETFs enthalten und somit ein eher allgemein bekannter Wert. Der Spitzenreiter UBS ETF (CH) SMI® gewichtet Novartis mit 16,90% im ETF.
Es ist auch möglich über Anleihen zu investieren. Hier findest du alle Novartis Anleihen auf einen Blick.
Entdecke die 6 ETFs in denen Novan, Inc am höchsten gewichtet ist Insgesamt in 80 ETFs enthalten
Dir gefallen die Informationen zu Novartis?
Galue bleibt auch in Zukunft kostenfrei und ungesponsort. Wenn Ihr meine Arbeit unterstützen möchtet, dann eröffnet gerne ein kostenloses und unverbindliches Depot bei Trade Republic mit der Möglichkeit kostenlos Aktien zu besparen. Wenn du das über meinen Link machst, bekommst du und ich bei deinem ersten Wertpapierkauf 15 von Trade Republic geschenkt:
Zu Trade Republic
Dir gefallen die Informationen zu Novartis?
Galue bleibt auch in Zukunft kostenfrei und ungesponsort. Wenn du meine Arbeit unterstützen möchtest, dann eröffne ein kostenloses und unverbindliches Depot bei BUX Zero mit der Möglichkeit kostenlos US-Aktien und für einen Euro viele weitere Aktien aus Deutschland, Belgien, Niederlande, sterreich oder UK zu kaufen. Wenn du das über meinen Link machst, bekommen wir beide eine gratis Aktie geschenkt:
Zu BUX Zero
Dir gefallen die Informationen zu Novartis?
Galue bleibt auch in Zukunft kostenfrei und ungesponsort. Wenn Ihr meine Arbeit unterstützen möchtet, dann eröffnet gerne ein mindestens 3 Jahre lang kostenloses Depot bei der comdirect. Wenn du das über diesen Link machst unterstützt du auch meine Tochter Zoe, da es Ihr Juniordepot ist. Sie erhält 20 und bei einem aktiven ETF- oder Aktien-Sparplan bleibt dein Depot auch danach kostenfrei:
Zur Comdirect
Dir gefallen die Informationen zu Novartis?
Galue bleibt auch in Zukunft kostenfrei und ungesponsort. Wenn du meine Arbeit unterstützen möchtest, dann eröffne gerne ein kostenloses und unverbindliches Depot bei der ING Diba. Ich erhalte 20 wenn du daraufhin dann zum Beispiel einen Aktien-Sparplan anlegst oder etwas kaufst:
Zur ING Diba
286 News & Informationen zur Novartis Aktie
Pfizer: The Rally Is Far From Finished
GuruFocus Article or News written by Nathan Parsh and the topic is about: The stock is up 16% since the earnings release, but could see double-digit returns on a modest multiple expansion.
Y-Intercept (Hong Kong) Ltd Buys KLA Corp, Archer-Daniels Midland Co, Regeneron Pharmaceuticals Inc, Sells Apple Inc, Baidu Inc, Baxter International Inc
GuruFocus Article or News written by insider and the topic is about:
Cathie Wood’s ARK Invest Sells Over 280,000 Shares of Twitter – 24
One of Cathie Wood's ARK Invest funds sold over 280,000 shares of Twitter on August 11.
Regenerative Medicine Market Size Worth $57.08 Billion By 2027: Grand View Research, Inc.
SAN FRANCISCO, Aug. 12, 2021 /PRNewswire/ — The global regenerative medicine market size is expected to reach USD 57.08 billion by 2027, growing …
Genmab Announces Financial Results for the First Half of 2021
– Operating result 1,500 – 2,400 1,000 – 2,000 Conference Call Genmab will hold a conference call to discuss the results for the first half of 2021 today, Wednesday,… | August 11, 2021
Cathie Wood’s ARK Invest Dumps Nearly $39 Million Worth of Netflix Stock – 24
One of Cathie Wood's ARK Invest funds sold over 75,000 shares of Netflix on August 10.
Eye Supplements Market Research Report 2021-2028 | Size, Share, Growth, Trends, Competitive Landscape, Revenue, Forecast Analysis
Key Prominent Players Covered in the Eye Supplements Market are Nature's Bounty Co., Amway Corp., Butterflies Healthcare Ltd, Valeant Pharmaceuticals…
Novartis Stock: 3 Reasons It May Be Your Ticket To A Rich Retirement (NYSE:NVS)
Novartis is a Swiss pharmaceutical giant that's demonstrated strong growth in recent years. It has solid profitability compared to peers, and has a robust pipeline of drugs.
Cathie Wood’s ARK Invest Sells for 8
Here's a look at the ARK Invest sells for August 10, 2021.
Shares of Eli Lilly Have Soared in Past 5 Years
GuruFocus Article or News written by Barry Cohen and the topic is about: Stock has gained nearly 80% in past year, 260% since 2016
Shares of Eli Lilly Have Soared in Past 5 Years
GuruFocus Article or News written by Barry Cohen and the topic is about: Stock has gained nearly 80% in past year, 260% since 2016
Shares of Eli Lilly Have Soared in Past 5 Years
GuruFocus Article or News written by Barry Cohen and the topic is about: Stock has gained nearly 80% in past year, 260% since 2016
Shares of Eli Lilly Have Soared in Past 5 Years
GuruFocus Article or News written by Barry Cohen and the topic is about: Stock has gained nearly 80% in past year, 260% since 2016
Shares of Eli Lilly Have Soared in Past 5 Years
GuruFocus Article or News written by Barry Cohen and the topic is about: Stock has gained nearly 80% in past year, 260% since 2016
Shares of Eli Lilly Have Soared in Past 5 Years
GuruFocus Article or News written by Barry Cohen and the topic is about: Stock has gained nearly 80% in past year, 260% since 2016
Shares of Eli Lilly Have Soared in Past 5 Years
GuruFocus Article or News written by Barry Cohen and the topic is about: Stock has gained nearly 80% in past year, 260% since 2016
Global Pharmaceutical Packaging Equipment Market to Reach $14.3 Billion by 2026
/PRNewswire/ — A new market study published by Global Industry Analysts Inc., (GIA) the premier market research company, today released its report titled…
REGENXBIO Reports Second Quarter 2021 Financial Results and Operational Highlights
/PRNewswire/ — Enrollment in RGX-314 programs is on-track, including the pivotal program for the treatment of wet AMD utilizing subretinal delivery, and the…
Were Hedge Funds Right About Pfizer Inc. (PFE)?
The 800+ hedge funds and famous money managers tracked by Insider Monkey have already compiled and submitted their 13F filings for the first quarter, which unveil their equity positions as of March 31st…
Were Hedge Funds Right About Merck & Co., Inc. (MRK)?
Our extensive research has shown that imitating the smart money can generate significant returns for retail investors, which is why we track nearly 900 active prominent money managers and analyze their…
Philip Morris, Carlyle could fight it out for UK's Vectura in auction ring By Reuters
Philip Morris, Carlyle could fight it out for UK's Vectura in auction ring
Report 2021, Eyewear Market Size | Is Projected to Reach USD 178.95 Billion by 2026 with 5.7% CAGR
Eyewear Market Key Players Studied in this Report are Alcon (Part of Novartis AG), EssilorLuxottica, CooperVision, Johnson & Johnson Services, Inc Bausch…
Smart Pills Global Market Report 2021: COVID-19 Growth and Changes to 2030
DUBLIN, Aug. 6, 2021 /PRNewswire/ — The 'Smart Pills Global Market Report 2021: COVID-19 Growth and Change to 2030' report has been added to Rese…
Drug Delivery Devices Global Markets Report 2021: COVID-19 Impacts, Implications And Growth Factors To 2030
DUBLIN, Aug. 6, 2021 /PRNewswire/ — The “Drug Delivery Devices Global Market Report 2021: COVID-19 Implications and Growth to 2030” report has been added to
The Vanguard Health Care Fund's Top 5 Trades of the 2nd Quarter
GuruFocus Article or News written by Graham Griffin and the topic is about: Fund pulls back its largest holding
Global $191 Billion Orphan Drugs Markets To 2026: Therapeutic Applications In Rare And Orphan Diseases, Regulatory Framework, Patents, And Innovations
DUBLIN, Aug. 5, 2021 /PRNewswire/ — The
Global Depression Treatment Market (2020 to 2026) – Featuring Allergen, Bausch Health Companies and Lief Therapeutics Among Others
/PRNewswire/ — The
Global Cancer Therapies Market to Reach $204.2 Billion by 2024
/PRNewswire/ — A new market study published by Global Industry Analysts Inc., (GIA) the premier market research company, today released its report titled…
Moderna Reports Second Quarter Fiscal Year 2021 Financial Results and Provides Business Updates
Moderna releases second quarter earnings and clinical update
Hot Biotech Stocks To Watch After Sanofi’s Acquisition Of Translate Bio
Bausch Health Companies Inc. : Announces Second-Quarter 2021 Results
by Segment
For the Three Months Ended June 30, 2021 and 2020
Calculation of Organic Revenue for the Three Months Ended
June 30, 2021
June 30, 2020
Change in
Organic… | August 3, 2021
Insights on the Targeted Therapeutics Global Market to 2031 – Featuring Sanofi, Takeda Pharmaceutical and Novartis Among Others
/PRNewswire/ — The “Targeted Therapeutics Market – Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2021-2031” report has been added to…
Insights on the Targeted Therapeutics Global Market to 2031 – Featuring Sanofi, Takeda Pharmaceutical and Novartis Among Others
DUBLIN, July 30, 2021 /PRNewswire/ — The 'Targeted Therapeutics Market – Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 202…
15 Most Valuable Biotech Companies in the World
In this article we will take a look at the 15 most valuable biotech companies in the world. You can skip our detailed analysis of the biotechnology industry…
Global Drug Delivery Systems (DDS) Markets 2021-2027 – Increasing R&D Expenditures Of Innovator Companies And The Trend Of Patent Portfolio Expansion
DUBLIN, July 29, 2021 /PRNewswire/ — The
Global Anti-epileptic Drugs Market to surpass US$ 7,344.9 Million by 2028, Says Coherent Market Insights (CMI)
SEATTLE, July 29, 2021 (GLOBE NEWSWIRE) — Global Anti-epileptic Drugs Market to surpass US$ 7,344.9 Million by 2028, Says Coherent Market Insights (CMI)…
Oragenics (NYSE American: $OGEN) Enters into Licensing Agreement with the National Research Council of Canada, to Pursue the Rapid Development of Next-Generation SARS-CoV-2 Vaccines
Biotech Stocks Are In Focus After Merck’s FDA Approval & 1 Stands Out
Global Polycythemia Vera Therapeutics Market to Surpass US$ 1,516.5 Million by 2028, Says Coherent Market Insights (CMI)
SEATTLE, July 27, 2021 (GLOBE NEWSWIRE) — According to Coherent Market Insights, the global polycythemia vera therapeutics market is estimated to be…
NOVARTIS AG : Gets a Buy rating from Morgan Stanley
Morgan Stanley analyst Mark Purcell maintains his Buy rating on the stock. The target price is set at 98 versus 99 CHF. | July 27, 2021